
Specialists in Unlicensed Medicine
At Pro Pharmaceuticals Group, we accelerate access to critical treatments when approved options are unavailable or clinically unsuitable. Staying true to our mission of Accelerating Access, Transforming Lives Worldwide, we bridge the gap to meet unmet medical needs, delivering essential unlicensed medicines.
Necesidad clĆnica insatisfecha
ā
Para un paciente con una enfermedad que necesita un tratamiento particular, es posible que no haya un producto disponible comercialmente en Australia disponible para tratar sus necesidades clĆnicas.
ā
Medicamentos sin licencia y programas de acceso administrado
ā
No todos los medicamentos estĆ”n aprobados en todos los paĆses, y puede haber pacientes que necesiten acceder a medicamentos no aprobados en sus paĆses.
ā
Un _cc781905-5cde -3194-bb3b-136bad5cf58d_Medicine (UL) sin licencia en Australia significa que actualmente no cuenta con la aprobaciĆ³n de registro/comercializaciĆ³n (MA) de nuestro regulador, la AdministraciĆ³n de productos terapĆ©uticos (TGA). Sin embargo, el medicamento en particular puede tener un registro/aprobaciĆ³n de comercializaciĆ³n actual en otra regiĆ³n del mundo, como el Reino Unido, EE. UU., Europa u otra regiĆ³n.
ā
Programa de Acceso Administrado (MAP) es un tĆ©rmino que usamos para definir un acuerdo mĆ”s formalizado con un Patrocinador. El suministro y la distribuciĆ³n de productos en particular se adaptarĆan a las solicitudes de los Patrocinadores. Esto puede adaptarse a una etapa del ciclo de vida previa a la aprobaciĆ³n, por ejemplo.
ā
ĀæPor quĆ© no estĆ” disponible en mi regiĆ³n?
ā
Producto quizĆ”s en desarrollo clĆnico aĆŗn no aprobado (tiempo)
Post ensayo clĆnico pero sin proceder a la aprobaciĆ³n (sin proceder a la comercializaciĆ³n en la regiĆ³n)
Puede estar aprobado en otro paĆs, por ejemplo, EE. UU., Europa o JapĆ³n.
Puede haber escasez en Australia
ā

Ensuring Access to Essential Medicines


Experience
Expertise in Unlicensed Medicines
With extensive experience and a patient-first approach, Pro Pharmaceuticals Group ensures reliable access to essential medicines for healthcare providers. Our global network connects with trusted suppliers to maintain the quality and availability of critical treatments. By focusing on timely and effective solutions, we help clinicians achieve the best possible outcomes for their patients.
ā
Partnering with Pro Pharmaceuticals Group gives healthcare professionals a dependable pathway to source medicines through approved regulatory frameworks. As a 100% Australian-owned company, we are committed to ethical sourcing, healthcare security, and delivering trusted supply solutions when they are needed most.
Pro Pharmaceuticals Group specialises in assisting healthcare providers in accessing unregistered medicines when no locally approved alternative exists. With deep expertise in regulatory frameworks and global supply chains, we facilitate compliant access through TGA-approved pathways.
ā
Our dedicated support team ensures immediate assistance, offering healthcare professionals access to a broad global network of licensed suppliers. Through a structured and ethical approach, we help bridge medicine availability gaps while upholding strict safety and compliance standards.


Collaborating with Global Pharmaceutical Manufacturers
How We Support Healthcare Providers
Pro Pharmaceuticals Group partners with leading pharmaceutical manufacturers, international wholesalers, and validated suppliers to ensure the secure and compliant supply of medicines. By maintaining strong relationships with globally licensed suppliers, we provide a consistent and structured supply chain for healthcare providers.
ā
Every medicine we source meets strict Good Distribution Practice (GDP) and Australian regulatory requirements, ensuring that hospitals, pharmacies, and clinical institutions receive high-quality treatments efficiently. Our commitment to compliance, safety, and ethical sourcing supports the secure distribution of essential medicines worldwide.
Accessing unregistered medicines requires specialised knowledge in regulatory compliance, logistics, and secure supply chains. Pro Pharmaceuticals Group works closely with hospitals, clinics, and pharmacies to ensure healthcare professionals can obtain essential medicines through approved legal pathways.
ā
By providing regulatory support, documentation assistance, and secure logistics coordination, we simplify the process for healthcare providers. Our role is to ensure healthcare professionals have access to critical treatments while maintaining the highest standards of safety, compliance, and reliability.